{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:18:25Z","timestamp":1781702305008,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Program of Beijing Natural Science Foundation of China","award":["Z220019"],"award-info":[{"award-number":["Z220019"]}]},{"name":"The National Key Research and Development Program of China","award":["2023YFC2507205"],"award-info":[{"award-number":["2023YFC2507205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03833-4","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T13:30:55Z","timestamp":1753191055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?"],"prefix":"10.1186","volume":"25","author":[{"given":"Meng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"38","key":"3833_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"2","key":"3833_CR2","doi-asserted-by":"publisher","first-page":"e12086","DOI":"10.1002\/pul2.12086","volume":"12","author":"A Arvanitaki","year":"2022","unstructured":"Arvanitaki A, Vrana E, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, Patrianakos A, Karyofyllis P, Mitrouska I, et al. The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE). Pulm Circ. 2022;12(2):e12086.","journal-title":"Pulm Circ"},{"issue":"2","key":"3833_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","volume":"168","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168(2):871\u201380.","journal-title":"Int J Cardiol"},{"issue":"1","key":"3833_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1378\/chest.10-0075","volume":"139","author":"AE Frost","year":"2011","unstructured":"Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest. 2011;139(1):128\u201337.","journal-title":"Chest"},{"key":"3833_CR5","doi-asserted-by":"crossref","unstructured":"Hjalmarsson C, R\u00e5degran G, Kylhammar D, Rundqvist B, Multing J, Nisell MD, Kjellstr\u00f6m B. Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension. Eur Respir J. 2018;51(5):1702310.","DOI":"10.1183\/13993003.02310-2017"},{"issue":"25 Suppl","key":"3833_CR6","doi-asserted-by":"publisher","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","volume":"62","author":"MD McGoon","year":"2013","unstructured":"McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013;62(25 Suppl):D51-59.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3833_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1378\/chest.11-3241","volume":"144","author":"AD Poms","year":"2013","unstructured":"Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(1):169\u201376.","journal-title":"Chest"},{"issue":"1","key":"3833_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.13-1900","volume":"146","author":"ME Pugh","year":"2014","unstructured":"Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR. Causes of pulmonary hypertension in the elderly. Chest. 2014;146(1):159\u201366.","journal-title":"Chest"},{"issue":"8","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","volume":"186","author":"Y Ling","year":"2012","unstructured":"Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186(8):790\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl K","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"K21","DOI":"10.1093\/eurheartj\/suz205","volume":"21","author":"IM Lang","year":"2019","unstructured":"Lang IM, Palazzini M. The burden of comorbidities in pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(Suppl K):K21-k28.","journal-title":"Eur Heart J Suppl"},{"issue":"4","key":"3833_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","volume":"68","author":"CF Opitz","year":"2016","unstructured":"Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, Scelsi L, D\u2019Alto M, Olsson KM, Ulrich S, et al. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. J Am Coll Cardiol. 2016;68(4):368\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3833_CR12","doi-asserted-by":"publisher","first-page":"204589402091485","DOI":"10.1177\/2045894020914851","volume":"10","author":"AJ Peacock","year":"2020","unstructured":"Peacock AJ, Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard LS, Pepke-Zaba J, Sheares KKK, et al. Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulm Circ. 2020;10(1):2045894020914851.","journal-title":"Pulm Circ"},{"issue":"12","key":"3833_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","volume":"39","author":"MM Hoeper","year":"2020","unstructured":"Hoeper MM, Pausch C, Gr\u00fcnig E, Klose H, Staehler G, Huscher D, Pittrow D, Olsson KM, Vizza CD, Gall H, et al. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. J Heart Lung Transplant. 2020;39(12):1435\u201344.","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"3833_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1413687","volume":"373","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Barber\u00e0 JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Gr\u00fcnig E, et al. Initial use of ambrisentan plus Tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015;373(9):834\u201344.","journal-title":"N Engl J Med"},{"issue":"12","key":"3833_CR15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.healun.2019.09.010","volume":"38","author":"VV McLaughlin","year":"2019","unstructured":"McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Gali\u00e8 N, Barber\u00e0 JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, et al. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. J Heart Lung Transplant. 2019;38(12):1286\u201395.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"3833_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ejhf.2369","volume":"24","author":"S Rosenkranz","year":"2022","unstructured":"Rosenkranz S, Channick R, Chin KM, Jenner B, Gaine S, Gali\u00e8 N, Ghofrani HA, Hoeper MM, McLaughlin VV, Du Roure C, et al. The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study. Eur J Heart Fail. 2022;24(1):205\u201314.","journal-title":"Eur J Heart Fail"},{"issue":"26","key":"3833_CR17","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","volume":"373","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Gali\u00e8 N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, et al. Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015;373(26):2522\u201333.","journal-title":"N Engl J Med"},{"key":"3833_CR18","doi-asserted-by":"crossref","unstructured":"Lewis RA, Thompson AAR, Billings CG, Charalampopoulos A, Elliot CA, Hamilton N, Hill C, Hurdman J, Rajaram S, Sabroe I, et al. Mild parenchymal lung disease and\/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. Eur Respir J. 2020;55(6):2000041.","DOI":"10.1183\/13993003.00041-2020"},{"issue":"6","key":"3833_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1183\/09031936.00184412","volume":"42","author":"P Trip","year":"2013","unstructured":"Trip P, Nossent EJ, de Man FS, van den Berk IA, Boonstra A, Groepenhoff H, Leter EM, Westerhof N, Gr\u00fcnberg K, Bogaard HJ, et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013;42(6):1575\u201385.","journal-title":"Eur Respir J"},{"issue":"5","key":"3833_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/annrheumdis-2019-216274","volume":"79","author":"M Kuwana","year":"2020","unstructured":"Kuwana M, Blair C, Takahashi T, Langley J, Coghlan JG. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. Ann Rheum Dis. 2020;79(5):626\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3833_CR21","doi-asserted-by":"publisher","first-page":"204589401987715","DOI":"10.1177\/2045894019877157","volume":"9","author":"A Arvanitaki","year":"2019","unstructured":"Arvanitaki A, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, Farmakis D, Feloukidis C, Giannakoulas G, Karvounis H, et al. Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Pulm Circ. 2019;9(3):2045894019877157.","journal-title":"Pulm Circ"},{"issue":"5","key":"3833_CR22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.chest.2015.11.008","volume":"149","author":"JA Rose","year":"2016","unstructured":"Rose JA, Cleveland JM, Rao Y, Minai OA, Tonelli AR. Effect of age on phenotype and outcomes in pulmonary arterial hypertension trials. Chest. 2016;149(5):1234\u201344.","journal-title":"Chest"},{"issue":"47","key":"3833_CR23","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","volume":"39","author":"D Kylhammar","year":"2018","unstructured":"Kylhammar D, Kjellstr\u00f6m B, Hjalmarsson C, Jansson K, Nisell M, S\u00f6derberg S, Wikstr\u00f6m G, R\u00e5degran G. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 2018;39(47):4175\u201381.","journal-title":"Eur Heart J"},{"issue":"4","key":"3833_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14017431.2016.1185532","volume":"50","author":"G R\u00e5degran","year":"2016","unstructured":"R\u00e5degran G, Kjellstr\u00f6m B, Ekmehag B, Larsen F, Rundqvist B, Blomquist SB, Gustafsson C, Hesselstrand R, Karlsson M, Kornhall B, et al. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000\u20132014. Scand Cardiovasc J. 2016;50(4):243\u201350.","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"3833_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-017-0523-2","volume":"17","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y, Hino M, Gemma A. Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study. BMC Pulm Med. 2017;17(1):1\u201314. https:\/\/doi.org\/10.1186\/s12890-017-0523-2.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3833_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-024-02895-0","volume":"24","author":"T Kashiwada","year":"2024","unstructured":"Kashiwada T, Tanaka Y, Tanaka T, Okano T, Saito Y, Seike M, et al. Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention\u2014prospective, single-center, randomized, parallel-group study. BMC Pulm Med. 2024;24(1):1\u201315.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"3833_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1086\/679995","volume":"5","author":"C Kholdani","year":"2015","unstructured":"Kholdani C, Fares WH, Mohsenin V. Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology. Pulm Circ. 2015;5(2):220\u20137.","journal-title":"Pulm Circ"},{"key":"3833_CR28","doi-asserted-by":"publisher","first-page":"2004066","DOI":"10.1183\/13993003.04066-2020","volume":"58","author":"S Valentin","year":"2021","unstructured":"Valentin S, Maurac A, Sitbon O, Beurnier A, Gomez E, Guillaumot A, et al. Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs. Eur Respir J. 2021;58:2004066.","journal-title":"Eur Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03833-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:50:13Z","timestamp":1757267413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03833-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03833-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent of all participants was obtained for participation in the study. This study was approved by the Medical Ethics Committee of Beijing Anzhen Hospital Affiliated to Capital Medical University (KS2022037).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}